Related Experiment Video
Updated: Jul 15, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Provision of laboratory services for lipid analysis in the United Kingdom
A C J Hutchesson1, M J O'Kane, R D Neely
1Department of Clinical Chemistry, Royal Bolton Hospital, Bolton, UK. Andrew.Hutchesson@rbh.nhs.uk
Insights
UK clinical biochemistry labs show room for improvement in lipid analysis and reporting. Routine provision of LDL- and non-HDL-cholesterol results, alongside treatment thresholds, is recommended to align with national guidelines for coronary heart disease prevention.
Area of Science:
- Clinical Biochemistry
- Cardiovascular Disease Prevention
- Laboratory Medicine
Background:
- National guidelines in the UK aim to reduce coronary heart disease (CHD) mortality.
- This audit evaluates the current provision of lipid analyses by UK Clinical Biochemistry services.
- The study supports the implementation of these national guidelines.
Purpose of the Study:
- To assess the current practices in lipid analysis provision by UK Clinical Biochemistry laboratories.
- To identify areas for improvement in lipid testing and reporting to support CHD prevention guidelines.
- To evaluate the interpretation and reporting of lipid profiles in clinical practice.
Main Methods:
- Audit standards were established based on published national guidelines.
- A questionnaire survey was distributed to all UK Clinical Biochemistry laboratories.
- Data on lipid profile components, reporting practices, and interpretation were collected.
Main Results:
- Routine lipid profiles including triglycerides, HDL-, LDL-cholesterol, and total:HDL cholesterol ratio were provided by 98%, 85%, 72%, and 44% of labs, respectively.
- Only 33% and 27% of labs analyzed triglycerides and HDL-cholesterol, respectively, when requested simply to measure cholesterol.
- Interpretation guidance and treatment thresholds were inconsistently reported, with only 20% referencing guidelines and 19 quoting secondary prevention thresholds.
Conclusions:
- Significant scope exists for enhancing lipid analysis provision and interpretive information.
- Laboratories should routinely report LDL-cholesterol and non-HDL-cholesterol.
- Reports should include treatment thresholds and targets aligned with current national guidelines to aid CHD prevention.
Background:
National guidelines have been developed in the UK to reduce coronary heart disease mortality. This audit assesses provision of lipid analyses by UK Clinical Biochemistry services to support their implementation.
Methods:
Audit standards were derived from published guidelines. A questionnaire based on these was circulated to all UK Clinical Biochemistry laboratories.
Results:
Of 108 replies, routine lipid profiles included triglycerides, HDL-, LDL-cholesterol and total:HDL cholesterol ratio in 98, 85, 72 and 44%, respectively. Only 33% and 27% analysed triglycerides and HDL, respectively, when asked simply to measure cholesterol. Seventy-six percent of the reports stated whether specimens were collected after fasting. For primary prevention, 46% of laboratories stated results should be interpreted in association with other risk factors; 20% referred explicitly to national/local guidelines. Only 19 laboratories quoted secondary prevention treatment thresholds for total cholesterol or LDL-cholesterol. Sixty laboratories occasionally added extra tests and/or interpretive comments. Eight laboratories appeared to provide no input from senior medical/scientific staff into report validation.
Conclusions:
These results indicate scope for improvement in the provision of lipid analyses and of information to support their interpretation. We recommend laboratories should routinely provide LDL- and non-HDL-cholesterol results, and that reports should quote treatment thresholds/targets in keeping with current guidelines.
